(Q36883458)

16 August 2017

Effects of hydrofluoroalkane and dry powder-formulated corticosteroids on sputum inflammatory markers in asthmatic patients (English)

1 reference

16 August 2017

0 references

0 references

5

Qutayba Hamid

1 reference

16 August 2017

H Hauber

1

1 reference

16 August 2017

Rame Taha

2

1 reference

16 August 2017

Celine Bergeron

3

1 reference

16 August 2017

Vladimir Migounov

4

1 reference

16 August 2017

Ron Olivenstein

6

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

16 August 2017

6

1 reference

Canadian Respiratory Journal

inferred from page(s)

published in

1 reference

16 August 2017

13

1 reference

16 August 2017

2

1 reference

16 August 2017

73-78

1 reference

Creative Commons Attribution 4.0 International

16 August 2017

start time

1 January 2006

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Localization of atrial natriuretic peptide mRNA and immunoreactivity in the rat heart and human atrial appendage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2539014

Fractional analysis of sequential induced sputum samples during sputum induction: evidence that different lung compartments are sampled at different time points

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2539014

Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2539014

Oral corticosteroids decrease eosinophil and CC chemokine expression but increase neutrophil, IL-8, and IFN-gamma-inducible protein 10 expression in asthmatic airway mucosa

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2539014

Fractional analysis of Th2-type cytokines in sequential samples of induced sputum

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2539014

Effect of HFA-flunisolide on peripheral lung inflammation in asthma

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2539014

Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone : a cross-over study in healthy volunteers

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2539014

A comparison of the lung deposition of budesonide from Easyhaler, Turbuhaler and pMDI plus spacer in asthmatic patients

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2539014

Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2539014

Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day) versus budesonide dry powder inhaler (800 micrograms/day) in asthma

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2539014

Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2539014

Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2539014

Lung function and immunopathological changes after inhaled corticosteroid therapy in asthma

4 September 2018

1 reference

12 December 2020

Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma

1 reference

12 December 2020

Deposition patterns with Turbuhaler

1 reference

12 December 2020

Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements

1 reference

12 December 2020

Distribution of inhaled fluticasone propionate between human lung tissue and serum in vivo

1 reference

12 December 2020

Inflammation of small airways in asthma

1 reference

12 December 2020

IL-4 and IL-5 mRNA expression in induced sputum of asthmatic subjects: comparison with bronchial wash

1 reference

12 December 2020

Hydrofluoroalkane-134a beclomethasone dipropionate, 400 microg, is as effective as chlorofluorocarbon beclomethasone dipropionate, 800 microg, for the treatment of moderate asthma

1 reference

12 December 2020

Long-term effects of corticosteroid nasal spray on nasal inflammatory cells in patients with perennial allergic rhinitis

1 reference

12 December 2020

Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma. Influence of inhaled corticosteroids

1 reference

12 December 2020

Induced sputum derives from the central airways: confirmation using a radiolabeled aerosol bolus delivery technique

1 reference

12 December 2020

Induction of nitric oxide synthase in asthma

1 reference

12 December 2020

Identifiers

DOI

10.1155/2006/648392

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

16550263

1 reference